StockDocs
Project by Matthew Castle Please send feedback to matthewgcastle@gmail.com
LONA

LeonaBio, Inc.

LONA Nasdaq Biological Products, (No Diagnostic Substances) EDGAR ↗
$7.47
+0.18 +2.47%

Key statistics

from XBRL data in SEC filings
Market cap
$70.2M
Revenue (TTM)
Net income (TTM)
-$130M
EPS (TTM)
$-24.09
P/E ratio
Dividend yield
Free cash flow
-$45.8M
Cash
$32.8M
Total assets
$71.6M
Gross margin
52-week range
$3.53 – $14.21

Recent SEC filings

40 most recent
Annual, quarterly & current reports
8-K Shareholder vote results Jun 23, 2026 10-Q Quarter ended 2026-03-31 May 7, 2026 8-K Results of operations (earnings release); Regulation FD disclosure May 7, 2026 10-K Fiscal year ended 2025-12-31 Mar 31, 2026 8-K/A Completed an acquisition or disposition Mar 31, 2026 8-K Results of operations (earnings release); Regulation FD disclosure Mar 26, 2026 8-K Director or officer change; Shareholder vote results; Other events Mar 19, 2026 8-K Director or officer change; Amended charter or bylaws; Regulation FD disclosure; Other events Jan 9, 2026 8-K/A Entered a material agreement; Unregistered sale of equity; Regulation FD disclosure; Other events Dec 18, 2025 8-K Entered a material agreement; Unregistered sale of equity; Regulation FD disclosure; Other events Dec 18, 2025 10-Q Quarter ended 2025-09-30 Nov 6, 2025 8-K Results of operations (earnings release); Regulation FD disclosure Nov 6, 2025 8-K Other events Oct 3, 2025 8-K Modified rights of security holders; Amended charter or bylaws Sep 11, 2025 10-Q Quarter ended 2025-06-30 Aug 7, 2025 8-K Results of operations (earnings release); Regulation FD disclosure Aug 7, 2025 8-K Shareholder vote results Jun 2, 2025 10-Q Quarter ended 2025-03-31 May 9, 2025 8-K Results of operations (earnings release); Regulation FD disclosure May 9, 2025 8-K Delisting notice or listing-rule failure Apr 16, 2025 10-K Fiscal year ended 2024-12-31 Feb 27, 2025 8-K Results of operations (earnings release); Regulation FD disclosure Feb 27, 2025 10-Q Quarter ended 2024-09-30 Nov 7, 2024 8-K Results of operations (earnings release); Regulation FD disclosure Nov 7, 2024 8-K Delisting notice or listing-rule failure; Other events Oct 18, 2024 8-K Director or officer change Oct 7, 2024 8-K Exit or disposal costs; Director or officer change Sep 17, 2024 8-K Regulation FD disclosure; Other events Sep 3, 2024 10-Q/A Quarter ended 2024-06-30 Aug 9, 2024 10-Q Quarter ended 2024-06-30 Aug 1, 2024 8-K Results of operations (earnings release); Regulation FD disclosure Aug 1, 2024 8-K Shareholder vote results May 29, 2024 8-K Other events May 17, 2024 10-Q Quarter ended 2024-03-31 May 15, 2024 8-K Results of operations (earnings release); Regulation FD disclosure May 15, 2024 10-K Fiscal year ended 2023-12-31 Feb 22, 2024 8-K Results of operations (earnings release); Director or officer change; Regulation FD disclosure Feb 22, 2024 8-K Results of operations (earnings release); Director or officer change Jan 8, 2024 10-Q Quarter ended 2023-09-30 Nov 9, 2023 8-K Results of operations (earnings release); Regulation FD disclosure Nov 9, 2023